ClinicalTrials.Veeva

Menu

Cohort IMEA 070 -Lenacapavir Compassional

I

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

Status

Active, not recruiting

Conditions

HIV Infections

Study type

Observational

Funder types

Other

Identifiers

NCT06289361
IMEA 070

Details and patient eligibility

About

Immunovirological follow-up and safety of HIV-infected patients receiving lenacapavir under compassionate access in France between 01/01/2021 and 12/31/2023

Full description

Retrospective descriptive cohort of patients who received Lenacapavir under compassionate access in France with 50 patients in 25 sites in France

Enrollment

58 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who received compassionate access to LEN between 01/01/2021 and 20/12/202

Exclusion criteria

  • Absence of visits with virological assessment subsequent to inclusion visit
  • Participant opposition to use of follow-up data

Trial contacts and locations

23

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems